XLerateHealth Accelerator Announces Incoming Fifth Cohort

LOUISVILLE, Ky.--(BUSINESS WIRE)--XLerateHealth, a Louisville-based accelerator for early-stage healthcare companies, announced it has selected eight companies to participate as part of its incoming fifth cohort. The accelerator’s 12-week intensive program will begin August 9, 2017 and run until “Demo Day” on October 26, 2017. Selected companies include:

Digital Health Solutions, LLC (Indianapolis, IN) delivers a clinical decision support system that engages patients, families, and clinicians to improve patient care and streamline documentation. Families are prescreened for clinical risk factors via an electronic tablet screener that presents questions tailored to each patient and medical records are analyzed by hundreds of decision rules to identify the most important items for the clinician to address. The system integrates with commercial EHRs. https://www.digitalhealthsolutionsllc.com/

Fourth Dimension Medical Solutions (Louisville, KY) is a medical software company that uses diffusion weighted magnetic resonance imaging and phase contrast imaging to assess the acute rejection state of a transplanted kidney. Used instead of biopsy, the non-invasive imaging is cheaper to conduct, provides faster results, does not expose the patient to infection or other complications, and provides high accuracy as each kidney can be individually assessed.

Innovative Therapeutix, Inc. (Louisville, KY) aims to reduce healthcare costs by developing innovative therapeutic devices to solve complex medical and developmental issues in infants and children. The first product under development addresses infant feeding problems by using a biofeedback baby bottle device. This unique and user-friendly technology will allow parents to support their child with feeding, thus preventing hospital readmissions, long-term feeding issues, and speech/language delays. www.innovativeTpx.com

MYNURSE (Lisbon, Portugal) MYNURSE is a mobile online platform that enables patients and their families to choose where, when, how and by whom they will be treated (at a predetermined hourly rate with a user-reported star rating system). The platform provides nurses, aides, physiotherapists, therapists (speech, occupational, osteopathy and acupuncture), and home palliative care teams within a preset distance from the client. MYNURSE launched in January 2017 and is available in 5 languages (Portuguese, English, Spanish, French and German). http://www.mynurse.pt

Pahoola (St. Louis, MO) is a patient education company that produces and distributes high quality, engaging video content to educate patients and family members about medical procedures before, during and after their hospital visit. A more educated and engaged patient results in improved outcomes and patient satisfaction while reducing post-discharge readmissions. Pahoola will ultimately cover 80 medical procedures, with a library of over 400 videos. http://www.pahoola.com.

RCM Brain (Louisville, KY) is an AI driven revenue cycle workflow automation platform that makes claims processing staff 3 to 10 times more productive. It uses artificially intelligent workflow bots to connect data and execute tasks across legacy billing systems, clearinghouses, and payer websites. Clients include internal revenue cycle departments and third party claims processing service providers. www.rcmbrain.com

Thaddeus Medical Systems (Rochester, MN) improves healthcare outcomes by tracking, protecting and documenting temperature-sensitive products and specimens through the supply chain. Solutions bridge the gap between price, quality and perception of value within cold chain packaging. Through patented technology and thoughtful innovation, its iQ+-ler™ and SmartSleeve™ actively maintain multiple temperature ranges, provide real-time condition and location updates, and reassure product quality and security through comprehensive reporting and analytics. https://thaddeusmed.com

TheraPeptics, LLC (Doylestown, PA) is an emerging AI enabled therapy discovery and development company focused on developing novel, nature inspired AMPs/host defense peptides from animals with superior immune systems, carried by novel drug delivery tools to the right place at the right time to cure animals and humans. Targets include viruses, bacteria, special immune cell subpopulations and cancer tissues of all types.

XLerateHealth has received sponsorship support from the Kentucky Cabinet for Economic Development – Office of Commercialization & Innovation, Louisville Metro Government, The U.S. Small Business Administration (SBA), the VOGT Invention & Innovation Fund, and ID&A Office and Interior Design. Supporting venture capital sponsors include Kentucky Enterprise Fund/KSTC (Lexington), OCA Ventures (Chicago), TriStar Ventures (Nashville), River Cities Capital (Cincinnati), and Chrysalis Ventures (Louisville). In kind sponsors include Frost Brown Todd and Argi (formerly OPM Financial). XLerateHealth’s partners include Creosalus, Louisville’s Cardiovascular Innovation Institute and The Nucleus Innovation Center. For more information, please visit www.XLerateHealth.com.